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To orchestrate immune responses, pathogen-recognition receptors have evolved sophisticated strategies to
monitor pathogenic processes. In this issue ofCell Host &Microbe, a study by Cho et al. reveals amechanism
of immune recognition that relies on the sensing of cholera toxin within the endoplasmic reticulum.Over the last two decades, various mech-
anisms have been elucidated by which
animal cells detect the presence of micro-
bial pathogens and mount an immune
response. These include Toll-like recep-
tors, present at the cell surface and in
endosomes to detect extracellular and
endosomal microbial products, and re-
ceptors such as Nod-like and RIG-I-like
receptors that ensure similar sensing in
the cytosol. Recently, it was found that
cells can even sense pathogen-induced
alterations in cytoplasmic ion composi-
tion and in cytoskeleton organization
and dynamics.
Yet some pathogen-derived products,
in particular certain bacterial toxins,
appear to remain undetected by the
innate immune system, even though they
enter the host cell to cause disease. One
such particularly clever and sneaky toxin
is cholera toxin (CT), the causative agent
of the watery diarrhea that characterizes
infection by the gram-negative bacterium
Vibrio cholerae (Wernick et al., 2010). CT
is an AB5 toxin, where the Amoiety carries
the enzymatic activity and the homopen-
tameric B moiety (CTB) is responsible for
binding the toxin to the target cell surface
and escorting it to the appropriate desti-
nation. In many toxins, the B subunit has
the capacity to translocate the A subunit
across a membrane, allowing it to reach
its cytosolic targets. CTB acts instead by
escorting CTA into the endoplasmic retic-
ulum, the only site of the endomembrane
system where protein transport across
the membrane to the cytosol normally
occurs. To reach this destination, CT has
evolved, in a masterly fashion, to cheat
its host, hiding its foreign origin and pass-
ing for a self-protein. The CTB pentamer
binds to GM1 gangliosides at the cell
surface, triggering an unconventional
internalization route of sphingolipid traf-ficking that targets CT first to endosomes
and then via retrograde transport to the
Golgi and endoplasmic reticulum (ER).
One of the mechanisms by which
eukaryotic cells localize soluble proteins
within the ER lumen, such as Bip and
other protein folding chaperones, is
through the presence of a C-terminal
KDEL sequence. This peptide motif is
recognized by the KDEL receptor present
in the early secretory pathway, which
functions to capture KDEL bearing pro-
teins as they ‘‘escape’’ the ER by bulk
flow in secretory vesicles en route to the
cis Golgi and recycle them back to the
ER. Through the presence of a KDEL
sequence at the C terminus of the A sub-
unit, CT hijacks this ER retrieval pathway
to localize within the ER lumen, at least
long enough for the second coup de
maıˆtre of CT coevolution to take place
(Fujinaga et al., 2003; Lencer et al.,
1995; Wernick et al., 2010).
Once inside the ER, the CT A subunit
somehow masquerades as a terminally
misfolded protein. It is recognized by the
ER quality control machinery, unfolded
with the help of ER chaperones/folding
enzymes, and targeted to the ER-associ-
ated degradation (ERAD) pathway for ret-
rotranslocation to the cytosol, basically
co-opting the machinery for degradation
of terminally misfolded endogenous pro-
teins in the secretory pathway. Transport
of misfolded proteins from the ER lumen
to the cytosol during ERAD is normally fol-
lowed by polyubiquitination and degrada-
tion by the proteasome. Yet, CT escapes
ubiquitination, refolds into its enzymati-
cally active conformation, and induces
disease (Wernick et al., 2010). Thus, CT
sneaks into the cell. It does not insert
exogenous pores or protein conducting
channels to breach cell membranes or
otherwise damage the host cell. Rather,Cell Host & Microbeit poses successfully as a host cell
protein, efficiently co-opting the normal
cellular mechanisms for lipid trafficking
and protein quality control in order to
reach its goal.
Cho et al. now reveal how this so far
thought to be ‘‘invisible’’ and ultimately
successful toxin does not pass unnoticed
(Cho et al., 2013). They find that CT is
detected by a surveillance mechanism
uniquely present within the lumen of the
ER that subsequently triggers the produc-
tion of proinflammatory cytokines such as
interleukin- 6 (IL-6) and IL-8. Cytokine
production in bothmice and tissue culture
is indeed observed with catalytically inac-
tive and retrotranslocation-deficient CTA
mutants, excluding the involvement of
cytosolic pattern-recognition receptors.
The ER plays a central role in maintain-
ing cellular homeostasis. It serves a
variety of key functions, including the
production of virtually all membrane and
secreted proteins. To cope with physio-
logical and pathological conditions that
challenge its functions, the ER displays
a remarkable capacity to adapt and
restore homeostasis. In particular, the
pathological or stress-induced accumula-
tion of unfolded/misfolded proteins in
the lumen is sensed by transmem-
brane signaling molecules that trigger a
transcriptional program known as the
unfolded protein response (UPR) (Walter
and Ron, 2011). IRE1a is the best-studied
and most-conserved branch of the UPR,
the only one present in lower eukaryotes.
It detects unfolded proteins within the ER
lumen and signals via an extension in
the cytosol that contains two functional
units: a protein kinase that serves as an
oligomerization platform and an endori-
bonuclease that targets cellular RNAs.
IRE1a activation triggers the expression
of an active XBP1 transcription factor by13, May 15, 2013 ª2013 Elsevier Inc. 501
Figure 1. Activation IRE1a by CT within the ER Triggers NF-kB and
Cytokine Release
The CT that reaches the lumen of the ER is formed by five units of its B subunit
and one subunit A. For translocation of the active A1 chain in the cytosol, the
A1 chain is first unfolded and then retrotranslocated via the ERADmachinery in
the cytoplasm. In the meantime, the ER-anchored stress sensor IRE1a detects
the unfolded A1 chain within the ER and is activated. IRE1a harbors an RNase
activity that on one hand converts XBP1 mRNA in its active form and on the
other hand degrades cellular RNAs. IRE1-processed RNAs are then detected
by the RIG-I pathogen recognition receptor that recruits its adaptor MAVS and
activates NF-kB and IRF3 transcription factors. The activation of NF-kB leads
to the production of inflammatory cytokines such as IL-8 and IL-6.
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the XBP1 messenger RNA
(mRNA) that changes its
translational reading frame.
Cho et al. found that CT-
induced cytokine production
depends on the IRE1a ribo-
nuclease activity, while not
requiring the other UPR ER
sensors. Surprisingly, it does
not involve XBP1, the best-
characterized downstream
IRE1a effector. In addition to
XBP1 activation, IRE1a can
degrade a pool of mRNAs
and microRNAs through a
process known as regulated
IRE1a-dependent decay
(RIDD) (Hetz et al., 2011; Hol-
lien and Weissman, 2006). It
shares this property with
RNaseL, a cytosolic endonu-
clease that evolved from
IRE1a to operate in host
defense against invading
viruses. Small self-RNA frag-
ments generated by RNaseL
in response to invading
viruses can activate the anti-
viral innate immune sensor
RIG-I (Malathi et al., 2007).Cho et al. found that self-RNAs generated
by IRE1a via CT-activated RIDD also
engage the RIG-I pathway to activate
the NF-kB pathway, leading to cytokine
release—this time in response to a micro-
bial product entering the ER (Figure 1).
Activation of RIG-I in response to viral
infection triggers two distinct pathways:
the production of type I interferon (IFN)
via the transcription factors IRF3 and
IRF7 and the production of inflammatory
cytokines via NF-kB. CT was found to
trigger both branches, but despite IRF3
activation, the resulting type I production
is modest compared to the induction of
inflammatory cytokines. These data are
intriguing and could reflect the specific
nature of the RNA fragments that are
generated by RIDD in response to CT.
These fragments do not harbor the 50 tri-
phosphates present in most viral RIG-I
agonists. They may therefore orchestrate
a specific RIG-I response skewed toward
NF-kB and inflammatory cytokine pro-
duction. Alternatively, other signals stem-
ming from IRE1a activation may impact
on type I IFN production in epithelial cells.
One possible mechanism could be the502 Cell Host & Microbe 13, May 15, 2013 ª2activation of XBP1, which binds the type
I IFN promoter in macrophages (Zeng
et al., 2010).
The study by Cho et al. highlights the
existence of a microbial surveillance
pathway in the lumen of the ER. It also
raises many questions regarding the
transcriptional response, as mentioned
above, and the mechanisms of recogni-
tion. Classically, activation of the UPR is
thought to occur when the ER content of
unfolded/misfolded proteins reaches a
given threshold. Analysis of the yeast
IRE1a structure suggests that the luminal
domain directly binds unfolded protein
segments, much like MHC complexes
bind antigenic peptides, and this leads
to oligomerization and activation of
IRE1a (Korennykh and Walter, 2012). It
is, however, well established that only
very few molecules of CT actually reach
the ER. It is therefore unlikely that the
threshold of unfolded proteins tolerated
by the ER is reached during CT intoxica-
tion, suggesting that activation occurs
through a more-specific recognition of
CTA by IRE1a. In line with this hypothesis,
Cho et al. show, using a peptide tiling013 Elsevier Inc.array and coimmunoprecipi-
tation, that two surface-
exposed sequences in CTA
can bind IRE1a. This binding
might have the ability to
activate IRE1a, at concentra-
tions far below that required
by unfolded proteins that
typify the canonical ER
stress response. The notion
that specific binding might
activate IRE1a is slightly
hampered by the observation
of Cho et al. that other patho-
gens/toxins, namely Shiga
toxin (ST) and the SV40 virus,
also activate the IRE1a-RIG-I
axis to trigger cytokine pro-
duction. Much like CT, ST
and SV40 bind gangliosides
at the cell surface to force
their way into the cells and
are transported via the retro-
grade pathway to the ER,
where they subsequently
cross the membrane to reach
the cytosol. The authors pro-
pose that IRE1a may have
evolved to sense the struc-
turally diverse CT, ST, and
SV40 capsid proteins bysomehow sensing common features
required for unfolding and retrotransloca-
tion to the cytosol. Alternatively, the toxins
and viruses might have independently
evolved, driven by as-yet-unknown selec-
tive forces, to bind IRE1a in a manner that
triggers activation; or perhaps activation
occurs through a more-generic binding
event that mimics the unfolded protein
response.
The discovery that the RIDD pathway
stemming from danger surveillance within
the ER can engage innate immune recep-
tors for virus invasion of the cytosol such
as RIG-I to trigger NF-kB activation
emphasizes the mechanistic and evolu-
tionary connection between cellular
stress responses and innate immune
pathways. Infections and diseases, such
as cystic fibrosis, inflammatory bowel
disease, atherosclerosis, and type 2 dia-
betes, display features characteristic
of both ER stress and inflammation,
including the activation of IRE1a, neutro-
phil, and macrophage infiltration. It
will be particularly important to address
the significance and physiological rele-
vance of IRE1a-mediated RIDD and
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these pathologies. Such studies will un-
doubtedly shed new light on the role of
the ER as a stress sensor that regulates
health, inflammation, and susceptibility
to infections.
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The mechanisms through which commensal bacterial populations cause inflammatory disease when shifted
to dysbiotic community structures are poorly understood. Jiao et al. (2013) demonstrate that, in the case
of inflammatory disease in the mouth, stimulation of the intracellular pattern recognition receptor Nod1 is
a critical determinant.Periodontal disease is one of the most
prevalent chronic inflammatory diseases
of humans and is characterized clinically
by the irreversible destruction of the
bony apparatus that secures the teeth in
the mouth. A hallmark of the disease is a
dysbiotic periodontal microbiota, which
has been extensively investigated by
cultural analysis over the last 50 years
and more recently by next-generation
sequence analysis of the complement of
16S ribosomal RNA genes in healthy
compared to diseased-associated micro-
biota (Wade, 2011). The rearrangement of
the normally benign commensal microbial
populations on the surface of the teeth
provides a sustained antigenic challenge
to the adjacent soft tissues, which, in
susceptible individuals, leads to a deregu-
lated inflammatory response and ulti-
mately resorption of the underlying hard
tissue. The precise mechanisms through
which the dysbiotic periodontal micro-
biota induces deregulated inflammation
are unknown. However, the end result,characterized by large elevations in
neutrophil trans-migration into the tissues
and the differentiation and activation
of bone-resorbing osteoclasts through
RANK ligand expression by CD4+
T cells, has been well established in both
human and animal model systems (Dar-
veau, 2010).
Twomousemodels of periodontal bone
loss have been customarily employed to
interrogate the pathogenesis of the dis-
ease. In the first, a bacterium frequently
associated with disease in humans, for
example Porphyromonas gingivalis, is
inoculated into the mouth of experimental
mice, leading to the induction of bone loss
some 6 weeks postcolonization. Hajish-
engallis et al. (2011) demonstrated that
bone loss in this model was dependent
upon the presence of a commensal mi-
crobiota: Colonization of germ-free ani-
mals with P. gingivalis results in no tissue
damage. Furthermore, analysis of the mi-
crobiota of conventionally reared mice
challenged with P. gingivalis demon-strated that introduction of this organism
caused a significant increase in the total
oral microbial load and dysbiosis of the
overall microbial community structure.
These data indicated that the presence
of P. gingivalis, even at a low abundance,
manipulates the commensal microbiota
into a dysbiotic community that leads to
the development of disease.
In the second model of disease, a silk
ligature is placed around selected molar
teeth in order to provide a site for
increased microbial accumulation and
tissue irritation. Just 10 days following
ligature placement, periodontal bone
loss is observed, indicative of an acute
response to this intervention. In the
current issue, Jiao et al. (2013) have
employed this model system in knockout
mice to determine which elements of
the pattern recognition receptor system
of the host are required to elicit this
destructive response. They demonstrate
that Nod1 (nucleotide-binding oligomeri-
zation domain-containing protein 1), a13, May 15, 2013 ª2013 Elsevier Inc. 503
